Physician profile
Joann Yi
NPI 1477783918
$1,895.34
in general payments reported to CMS, 2019-2025
17 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $545 · 2020: $376 · 2021: $368 · 2022: $65.13 · 2023: $157 · 2024: $130 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $339.46 | 2019-2021 | |
| Pfizer INC. | $226.65 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $223.41 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $202.67 | 2019-2021 | |
| Amgen INC. | $134.00 | 2019-2025 | Otezla, Repatha, Prolia |
| Abbvie INC. | $117.70 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.30 | 2019-2024 | Jardiance |
| Astellas Pharma US INC | $111.82 | 2019-2025 | Veozah |
| Kowa Pharmaceuticals America, INC. | $106.09 | 2019-2024 | Livalo |
| Lilly USA, LLC | $56.57 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $56.43 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $45.58 | 2019-2022 | |
| Agepha Pharma Fz LLC | $44.73 | 2025 | Lodoco |
| Eisai INC. | $38.26 | 2021-2022 | |
| Seqirus USA INC | $32.69 | 2019-2025 | Flucelvax, Fluad |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $28.47 | 2025 | Cologuard Collection Kit |
| Ibsa Pharma INC. | $14.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joann Yi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.